Low molecular weight heparin for neonatal thrombosis

Journal of Paediatrics and Child Health

Volumn 38, Issue 6, 2002, Pages 615-617

  Shama, A ^a   Patole, S K ^a   Whitehall, J S ^a  

^a TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Heparin; Neonate; Thrombosis

Indexed keywords

ANTITHROMBIN III; CEFOTAXIME; FLUCLOXACILLIN; LOW MOLECULAR WEIGHT HEPARIN; PENICILLIN G; PROTEIN C; PROTEIN S;

APNEA; ARTICLE; BLEEDING TENDENCY; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD CULTURE; BLOOD SAMPLING; BLOOD TRANSFUSION; CASE REPORT; CENTRAL VENOUS CATHETER; CEREBROSPINAL FLUID EXAMINATION; CESAREAN SECTION; DISEASE COURSE; DOPPLER FLOWMETER; DRUG INFUSION; ELECTIVE SURGERY; FIBRINOGEN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; ILIAC VEIN; INDWELLING CATHETER; LEG SWELLING; MALE; MATERNAL DIABETES MELLITUS; MENINGITIS; NEWBORN; PALLOR; PERIPHERAL VEIN; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; SAPHENOUS VEIN; SEPTIC SHOCK; SEPTICEMIA; SHOCK; STREPTOCOCCUS MITIS; THROMBOCYTOPENIA; THROMBOSIS;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ILIAC VEIN; INFANT, NEWBORN; MALE; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 0036434989     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2002.00052.x     Document Type: Article

References (19)

1. Dix D, Andrew M, Marzinotto V et al. The use of low molecular weight heparin in pediatric patients: A prospective cohort study. Pediatrics 2000; 136: 439-45.
2. Andrew M, Marzinotto V, Blanchette V et al. Heparin therapy in pediatric patients: A prospective cohort study. Pediatr. Res. 1994; 35: 78.
3. Andrew M, Marzinotto V, Brooker L et al. Oral anticoagulant therapy in paediatric patients: A prospective study. Thromb. Haemost. 1994; 71: 265.
4. David M, Andrew M. Venous thromboembolic complications in children. J. Pediatr. 1993; 123: 337-46.
5. Chalmers EA. Neonatal thrombosis. J. Clin. Pathol. 2000; 53: 419-23.
6. Edstrom CS, Christensen RD. Evaluation and treatment of thrombosis in the neonatal intensive care unit. Clin. Perinatol. Neonatol. Hematol. 2000; 27: 623-41.
7. Schmidt B. The etiology, diagnosis and treatment of thrombotic disorders in newborn infants: A call for international and multi-institutional studies. Semin. Perinatol. 1997; 21: 86-9.
8. Klinger G, Hellmann J, Daemon A. Severe aortic thrombosis in the neonate-successful treatment with low-molecular-weight-heparin. Two case reports and review of literature. Am. J. Perinatol. 2000; 17: 151-8.
9. Dzumhur SM, Goss DE, Cohen AT. Low-molecular-weight-heparin for venous thrombosis. Lancet 1995; 346: 1487.
10. Sherman GG, Munster M, Govendrageloo K, Harrisberg J, Levin SE. Low molecular weight heparin in the successful treatment of a spontaneous aortic thrombosis in a neonate. Pediatr. Hematol. Oncol. 2000; 17: 409-13.
11. Dunaway K, Gal P, Ransom JL. Use of Enoxaparin a preterm infant. Ann. Pharmacotherapy 2000; 34: 1410-13.
12. Punzalen RC, Hillery CA, Montgomery R, Scott JP, Gill JC. Low molecular weight heparin in thrombotic disease in children and adolescents. Pediatr. Hematol. Oncol. 2000; 22: 137-42.
13. Nohe N, Flemmer A, Rimler R, Praun M, Auberger K. The low molecular weight heparin dalteparin for prophylaxis and thrombosis in childhood: A report of 48 cases. Eur. J. Pediatr. 1999; 158: S134-S139.
14. Massicotte P, Adams M, Marzinotto V, Brooker L, Andrew M. LMWH in pediatric patients - A dose finding study. Pediatrics 1996; 128: 313-18.
15. Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 2001; 119: 344S.
16. Furedar W, Kyrle PA, Gisslinger H, Lechner K. Low-molecular-weight-heparin induced skin necrosis. Ann. Hematol. 1998; 77: 127-30.
17. Monreal M, Lafoz E, Salvador R, Roncales J, Navarro A. Adverse effects of three different forms of heparin therapy. Thrombocytopenia, increased transaminases, and hyperkalemia. Eur. J. Clin. Pharmacol. 1989; 37: 415-18.
18. Shaughnessy SG, Young E, Deschamps P, Hirsh J. The effects of low molecular weight heparin and standard heparin on calcium loss from fetal rat calveria. Blood 1995; 86: 1368.
19. Byun Y, Singh VK, Yang VC. Low molecular weight protamine: A potential nontoxic heparin antagonist. Thromb. Res. 1999; 94: 53-61.